Characterization of immunomodulatory activity of eIF4A protein
2011

Study of eIF4A Protein as an Immunomodulator

publication Evidence: moderate

Author Information

Author(s): Barhoumi Mourad, Koutsoni Olga, Guizani Ikram, Dotsika Eleni

Primary Institution: Institut Pasteur de Tunis

Hypothesis

Can eIF4A protein be validated as a natural adjuvant?

Conclusion

eIF4A proteins can activate dendritic cells and induce inflammation, suggesting their potential use in vaccines or immunotherapy.

Supporting Evidence

  • eIF4A proteins activated dendritic cells to express co-stimulatory molecules.
  • eIF4A proteins induced the production of IL-12p40/p70 and iNOS in vitro.
  • Injection of eIF4A proteins caused inflammation similar to the adjuvant Alum.

Takeaway

The eIF4A protein helps the immune system work better, which could be useful for vaccines.

Methodology

The study involved expressing and purifying eIF4A proteins and assessing their effects on dendritic cells in mice.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication